Goldman Sachs
EOLS icon

Goldman Sachs’s Evolus EOLS Stock Holding History

Goldman Sachs’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.47M Buy
1,086,398
+735,656
+210% +$3.56M ﹤0.01% 3814
2025
Q4 		$2.33M Sell
350,742
-106,955
-23% -$725K ﹤0.01% 4439
2025
Q3 		$2.81M Buy
457,697
+160,993
+54% +$1.26M ﹤0.01% 4175
2025
Q2 		$2.73M Sell
296,704
-65,216
-18% -$667K ﹤0.01% 3934
2025
Q1 		$4.35M Sell
361,920
-53,757
-13% -$703K ﹤0.01% 3495
2024
Q4 		$4.59M Buy
415,677
+105,095
+34% +$1.48M ﹤0.01% 3526
2024
Q3 		$5.03M Buy
310,582
+156,424
+101% +$2.19M ﹤0.01% 3339
2024
Q2 		$1.67M Sell
154,158
-32,117
-17% -$395K ﹤0.01% 4052
2024
Q1 		$2.61M Buy
186,275
+47,962
+35% +$623K ﹤0.01% 3664
2023
Q4 		$1.46M Sell
138,313
-33,837
-20% -$303K ﹤0.01% 4161
2023
Q3 		$1.57M Buy
172,150
+1,519
+0.9% +$13.6K ﹤0.01% 3949
2023
Q2 		$1.24M Buy
170,631
+34,632
+25% +$299K ﹤0.01% 4201
2023
Q1 		$1.15M Buy
135,999
+2,406
+2% +$21.8K ﹤0.01% 4283
2022
Q4 		$1M Buy
133,593
+41,859
+46% +$324K ﹤0.01% 4420
2022
Q3 		$738K Sell
91,734
-56,750
-38% -$602K ﹤0.01% 4714
2022
Q2 		$1.72M Buy
148,484
+58,943
+66% +$695K ﹤0.01% 4169
2022
Q1 		$1M Sell
89,541
-211,467
-70% -$1.8M ﹤0.01% 4810
2021
Q4 		$1.96M Buy
301,008
+9,641
+3% +$66.1K ﹤0.01% 4271
2021
Q3 		$2.22M Sell
291,367
-25,010
-8% -$259K ﹤0.01% 4099
2021
Q2 		$4M Buy
316,377
+243,101
+332% +$2.67M ﹤0.01% 3548
2021
Q1 		$952K Buy
73,276
+35,039
+92% +$323K ﹤0.01% 4652
2020
Q4 		$128K Buy
38,237
+3,924
+11% +$14.7K ﹤0.01% 5245
2020
Q3 		$134K Buy
34,313
+7,728
+29% +$28.2K ﹤0.01% 5020
2020
Q2 		$141K Sell
26,585
-23,061
-46% -$106K ﹤0.01% 4901
2020
Q1 		$206K Sell
49,646
-431,443
-90% -$3.66M ﹤0.01% 4694
2019
Q4 		$5.86M Buy
481,089
+459,829
+2,163% +$6.48M ﹤0.01% 2832
2019
Q3 		$332K Buy
21,260
+9,784
+85% +$160K ﹤0.01% 4637
2019
Q2 		$168K Sell
11,476
-33,489
-74% -$664K ﹤0.01% 4840
2019
Q1 		$1.01M Sell
44,965
-20,019
-31% -$433K ﹤0.01% 4047
2018
Q4 		$773K Buy
64,984
+25,196
+63% +$359K ﹤0.01% 4117
2018
Q3 		$741K Buy
+39,788
New +$862K ﹤0.01% 4205
2018
Q2 		– Sell
-15,205
Closed -$137K – 5745
2018
Q1 		$137K Buy
+15,205
New +$174K ﹤0.01% 5162

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs's EOLS Position: Q1 2026 in Review

Goldman Sachs increased its Evolus (EOLS) stake by 210% in Q1 2026, buying an estimated $3.56M and bringing the position to 1,086,398 shares worth $4.47M. The position accounts for ﹤0.01% of the portfolio, ranked #3814.

Goldman Sachs first reported a position in EOLS in Q1 2018 and has held it in 32 quarters since. The position peaked at $5.86M in Q4 2019. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • Goldman Sachs held 1,086,398 shares of Evolus worth $4.47M as of Q1 2026.
  • Goldman Sachs bought 735,656 Evolus shares in Q1 2026, an estimated $3.56M.
  • Evolus made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3814 holding.
  • Goldman Sachs first reported a position in Evolus in Q1 2018 and has held it in 32 quarters since.
  • Goldman Sachs's Evolus position peaked at $5.86M in Q4 2019.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.